Literature DB >> 21752583

Fungal periprosthetic hip and knee joint infections clinical experience with a 2-stage treatment protocol.

Konstantinos Anagnostakos1, Jens Kelm, Eduard Schmitt, Jochen Jung.   

Abstract

Fungal periprosthetic joint infections are a rare entity in orthopedic surgery, and there exist no guidelines according to which these infections can be successfully managed. Between 2004 and 2009, 7 patients with fungal periprosthetic joint infections (4 total hip arthroplasties and 3 total knee arthroplasties) have been treated with a 2-stage protocol and implantation of antibiotic-loaded cement spacers. Most of the infection was caused by Candida species. Systemic antifungal agents were administered for 6 weeks in 6 cases and 6 months in 1 case. The mean spacer implantation time was 12 weeks. At a mean follow-up of 28 months (5-70 months), no persistence of infection or reinfection could be observed. A 2-stage treatment protocol with implantation of an antibiotic-loaded cement spacer is an efficient option in the treatment of fungal periprosthetic infections.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21752583     DOI: 10.1016/j.arth.2011.04.044

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  25 in total

1.  Voriconazole is cytotoxic at locally delivered concentrations: a pilot study.

Authors:  Kenneth Schmidt; Alex McLaren; Christine Pauken; Ryan McLemore
Journal:  Clin Orthop Relat Res       Date:  2013-10       Impact factor: 4.176

Review 2.  The Role of One-Stage Exchange for Prosthetic Joint Infection.

Authors:  Fiachra E Rowan; Matthew J Donaldson; Jurek R Pietrzak; Fares S Haddad
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

3.  Candida periprosthetic infection of the hip: a systematic review of surgical treatments and clinical outcomes.

Authors:  Federico Fusini; Alessandro Aprato; Alessandro Massè; Alessandro Bistolfi; Massimo Girardo; Stefano Artiaco
Journal:  Int Orthop       Date:  2019-06-28       Impact factor: 3.075

4.  Candida periprosthetic infection of the knee: a systematic review of surgical treatments and clinical outcomes.

Authors:  Federico Fusini; Gabriele Colò; Alessandro Rava; Luigi Sabatini; Alessandro Massè; Alessandro Aprato; Stefano Artiaco
Journal:  Eur J Orthop Surg Traumatol       Date:  2022-02-19

5.  Use of Fluconazole-impregnated Beads to Treat Osteomyelitis Caused by Coccidioides in a Pigtailed Macaque (Macaca nemestrina).

Authors:  Charlotte E Hotchkiss; Dean A Jeffery; Keith W Vogel
Journal:  Comp Med       Date:  2022-07-14       Impact factor: 1.565

6.  Recurrent Failures After 2-Stage Exchanges are Secondary to New Organisms Not Previously Covered by Antibiotics.

Authors:  Fortune J Egbulefu; JaeWon Yang; John C Segreti; Scott M Sporer; Antonia F Chen; Matthew S Austin; Craig J Della Valle
Journal:  Arthroplast Today       Date:  2022-08-27

7.  Econazole-releasing porous space maintainers for fungal periprosthetic joint infection.

Authors:  Alexander M Tatara; Allison J Rozich; Panayiotis D Kontoyiannis; Emma Watson; Nathaniel D Albert; George N Bennett; Antonios G Mikos
Journal:  J Mater Sci Mater Med       Date:  2018-05-11       Impact factor: 3.896

8.  Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America.

Authors:  Peter G Pappas; Carol A Kauffman; David R Andes; Cornelius J Clancy; Kieren A Marr; Luis Ostrosky-Zeichner; Annette C Reboli; Mindy G Schuster; Jose A Vazquez; Thomas J Walsh; Theoklis E Zaoutis; Jack D Sobel
Journal:  Clin Infect Dis       Date:  2015-12-16       Impact factor: 9.079

9.  What is the success of treatment of hip and knee candidal periprosthetic joint infection?

Authors:  Steve W N Ueng; Ching-Yu Lee; Chih-chien Hu; Pang-Hsin Hsieh; Yuhan Chang
Journal:  Clin Orthop Relat Res       Date:  2013-04-30       Impact factor: 4.176

10.  Inhibitory Effect of 5-Aminoimidazole-4-Carbohydrazonamides Derivatives Against Candida spp. Biofilm on Nanohydroxyapatite Substrate.

Authors:  C Gabriel; L Grenho; F Cerqueira; R Medeiros; A M Dias; A I Ribeiro; M F Proença; M H Fernandes; J C Sousa; F J Monteiro; M P Ferraz
Journal:  Mycopathologia       Date:  2019-11-02       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.